Skip to main content
. 2021 Nov 10;10(22):e023199. doi: 10.1161/JAHA.121.023199

Table 2.

Overview of Cardiovascular Events

All patients (n=920) Low‐risk CoA* (n=376) High‐risk CoA (n=544)
No. of cases Incidence per 1000 patient‐y No. of cases Incidence per 1000 patient‐y No. of cases Incidence per 1000 patient‐y
CAD 14 1.6 4 1.3 10 1.9
Myocardial infarction 6 0.7 1 0.3 5 0.9
Coronary revascularization 6 0.7 2 0.6 4 0.7
Stable angina, medically treated 2 0.2 1 0.3 1 0.2
Stroke/TIA 34 4.0 9 2.8 25 4.7
Ischemic stroke 18 2.1 5 1.6 13 2.4
Hemorrhagic stroke, intracerebral 1 0.1 1 0.3 0 0
Hemorrhagic stroke, subarachnoidal 1 0.1 0 0 1 0.2
TIA 14 1.6 3 0.9 11 2.1
Aortic complication 84 9.9 16 5.1 68 12.7
Aneurysm 77 9.0 15 4.7 62 11.6
Dissection 7 0.8 1 0.3 6 1.1
Arrhythmia 84 9.9 22 6.9 62 11.6
Supraventricular arrhythmia 58 6.8 15 4.7 43 8.0
Ventricular arrhythmia 18 2.1 4 1.3 14 2.6
Conduction disturbance 8 0.9 3 0.9 5 0.9
Heart failure hospitalization 15 1.8 6 1.9 9 1.7
Endocarditis 15 1.8 2 0.6 13 2.4
Cardiovascular death 24 2.8 8 2.5 16 3.0
Total cardiovascular events 270 31.7 67 21.1 203 38.0
No. of individual patients with cardiovascular event 191 NA 48 NA 143 NA

CAD indicates coronary artery disease; NA, not applicable; and TIA, transient ischemic attack.

*

Includes patients with isolated coarctation of the aorta (CoA) or patients with any of the following associated lesions: closed or small ventricular septal defect, atrial septal defect, patent foramen ovale, or patent ductus arteriosus.

Includes patients with a bicuspid aortic valve, left‐sided mechanical heart valve, and/or Turner syndrome.